ArticleDigital health
Users' perspectives about challenges of using telemedicine for patient with diabetes during the COVID-19 pandemic.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Telemedicine services have been recognized as a safe and affordable method for providing continuous healthcare services, especially to patients with chronic diseases. Despite all advantages, the use of this technology has faced several challenges particularly during COVID-19. The aim of this study was to investigate physicians' and patients' with diabetes perspectives about challenges of using telemedicine during the COVID-19 pandemic. Methods: This survey study was conducted in 2023. The participants were endocrinologists, internal medicine specialists, general practitioners (GPs), and patients with diabetes in five teaching hospitals located in one of the underprivileged areas in Iran. Data were collected using a 5-point Likert-scale questionnaire and analyzed using descriptive statistics and the Kruskal-Wallis test. Results: In this study, 95 questionnaires were completed by 60 patients with diabetes (30%), 21 GPs (70%), 10 internal medicine specialists (66.6%), and 4 endocrinologists (80%). The results showed that technical (4.42 ± 0.57), clinical (4.25 ± 0.52), organizational (4.23 ± 0.56), and individual (4.02 ± 0.42) challenges were the most important challenges, respectively. However, there was a statistically significant difference between the perspectives of the specialists, GPs, and patients with diabetes in terms of individual, clinical, technical, and organizational challenges. Conclusions: Since the use of telemedicine for patients with diabetes faced several challenges during the COVID-19 pandemic, it is necessary to consider practical solutions to overcome these challenges in order to improve quality of services and increase the use of this technology, particularly in underprivileged areas. Moreover, the effectiveness of these services in different contexts, and for people with different economic conditions should be investigated in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.